Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer

Fig. 3

Western blotting detection of CXCL13 protein in patients with breast cancer. a Expression levels of CXCL13 protein were assessed by Western blotting analysis and normalized to GAPDH. TY1–6 and TO1–6 represented randomly selected cancer tissues from young women group and older women group, respectively, and NY1–6 and NO1–6 represented the randomly selected corresponding adjacent normal tissues from young women group and older women group, respectively. b A semi-quantitative analysis of the Western blotting of CXCL13 protein was performed between cancer tissues (n = 12) and their corresponding adjacent normal tissues (n = 12). c A semi-quantitative analysis of the Western blotting of CXCL13 protein in cancer tissues between young patients (n = 6) and their older counterparts (n = 6). *P < 0.05

Back to article page